Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease Beyond Fibrosis: Metabolic, Microbial, and Immune Determinants
Journal of Visualized Experiments · 2026
DOI: 10.3791/73743 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Zheng-Ying Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comprehensive Surgery, The First Hospital of Jilin University. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Fatty Liver, Liver Neoplasms, Metabolic Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Comprehensive Surgery, The First Hospital of Jilin University.
- Changchun Jirun Jingyue Hospital, The First Hospital of Jilin University.
- Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University; jiaoyan@jlu.edu.cn.
Zitieren
APA
Wang, Z. Y., Song, C. C., & Jiao, Y. (2026). Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease Beyond Fibrosis: Metabolic, Microbial, and Immune Determinants. Journal of Visualized Experiments. https://doi.org/10.3791/73743
Vancouver
Wang ZY, Song CC, Jiao Y. Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease Beyond Fibrosis: Metabolic, Microbial, and Immune Determinants. Journal of Visualized Experiments. 2026. doi:10.3791/73743
BibTeX
@article{Wang2026,
author = {Wang, Zheng-Ying and Song, Cheng-Cheng and Jiao, Yan},
title = {Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease Beyond Fibrosis: Metabolic, Microbial, and Immune Determinants},
journal = {Journal of Visualized Experiments},
year = {2026},
doi = {10.3791/73743}
}
EUVIMED